Via Therapeutics

Business Services · Texas, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

11113 Alison Park Trl, Austin, Texas, 78...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Via Therapeutics

Via Therapeutics LLC is dedicated to advancing therapies for global populations through innovative drug delivery technologies. Founded in 2018, the company focuses on enhancing user experiences by providing comprehensive technological solutions for industry leaders. Their platform technologies address a variety of diseases with advanced delivery techniques, including inhaled and nasal medications, subcutaneous nanoparticles, and oral solid dosage forms. Via Therapeutics aims to be the technological standard in the industry, continuously researching and developing solutions to meet market needs.Explore more
Popular SearchesVia TherapeuticsVia Therapeutics LLCCloXero Therapeutics IncViatherapeuticsSIC Code 87,873NAICS Code 54,541Show more

Via Therapeutics Org Chart

PhoneEmail
John Koleng, President and CSO at Via Therapeutics
United States flag for contact location.

President and CSO

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Via Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Via Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Via Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Via Therapeutics.

Via Therapeutics Tech Stack

A closer look at the technologies used by Via Therapeutics

Top Business Services Companies

Frequently Asked Questions Regarding Via Therapeutics

What is Via Therapeutics's official website?
Via Therapeutics's official website is www.viatherapeutics.com
What is Via Therapeutics's Revenue?
Via Therapeutics's revenue is <$5 Million
What is Via Therapeutics's SIC code?
Via Therapeutics's SIC: 87,873
What is Via Therapeutics's NAICS code?
Via Therapeutics's NAICS: 54,541
How many employees does Via Therapeutics have?
Via Therapeutics has 1-10 employees
What industry does Via Therapeutics belong to?
Via Therapeutics is in the industry of: Business Services, Research & Development
What technology does Via Therapeutics use?
Some of the popular technologies that Via Therapeutics uses are: Sentry, Microsoft 365, Yahoo Small Business Web Hosting, DigiCert
What does Via Therapeutics do?

Via Therapeutics LLC is dedicated to advancing therapies for global populations through innovative drug delivery technologies. Founded in 2018, the company focuses on enhancing user experiences by providing comprehensive technological solutions for industry leaders. Their platform technologies address a variety of diseases with advanced delivery te... chniques, including inhaled and nasal medications, subcutaneous nanoparticles, and oral solid dosage forms. Via Therapeutics aims to be the technological standard in the industry, continuously researching and developing solutions to meet market needs.Read More

Is Via Therapeutics a public company?
Via Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Via Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.